DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Non-coding RNAs linked to immortality and associated methods and compositions

Abstract

Aspects of the present disclosure include RNAs that confer a mortal phenotype and nucleic acids encoding same. Liposomes, recombinant cells, and pharmaceutical compositions that include the RNAs or nucleic acids encoding same are also provided. Further provided are methods involving quantifying MORT RNAs and/or determining the methylation status of the MORT promoter, as well as methods that employ the RNAs or nucleic acids encoding same.

Inventors:
; ; ;
Issue Date:
Research Org.:
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1771741
Patent Number(s):
10870851
Application Number:
15/764,255
Assignee:
THThe Regents of the University of California (Oakland, CA); Arizona Board of Regents on Behalf of the University of Arizona (Tucson, AZ)
Patent Classifications (CPCs):
C - CHEMISTRY C12 - BIOCHEMISTRY C12N - MICROORGANISMS OR ENZYMES
DOE Contract Number:  
AC02-05CH11231
Resource Type:
Patent
Resource Relation:
Patent File Date: 10/05/2016
Country of Publication:
United States
Language:
English

Citation Formats

Stampfer, Martha R., Garbe, James C., Vrba, Lukas, and Futscher, Bernard W. Non-coding RNAs linked to immortality and associated methods and compositions. United States: N. p., 2020. Web.
Stampfer, Martha R., Garbe, James C., Vrba, Lukas, & Futscher, Bernard W. Non-coding RNAs linked to immortality and associated methods and compositions. United States.
Stampfer, Martha R., Garbe, James C., Vrba, Lukas, and Futscher, Bernard W. Tue . "Non-coding RNAs linked to immortality and associated methods and compositions". United States. https://www.osti.gov/servlets/purl/1771741.
@article{osti_1771741,
title = {Non-coding RNAs linked to immortality and associated methods and compositions},
author = {Stampfer, Martha R. and Garbe, James C. and Vrba, Lukas and Futscher, Bernard W.},
abstractNote = {Aspects of the present disclosure include RNAs that confer a mortal phenotype and nucleic acids encoding same. Liposomes, recombinant cells, and pharmaceutical compositions that include the RNAs or nucleic acids encoding same are also provided. Further provided are methods involving quantifying MORT RNAs and/or determining the methylation status of the MORT promoter, as well as methods that employ the RNAs or nucleic acids encoding same.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2020},
month = {12}
}

Works referenced in this record:

Evaluation of Eosinophilic Esophagitis
patent-application, October 2009


Markers for Bladder Cancer Detection
patent-application, November 2010


Human cytosolic sulfotransferase database mining: identification of seven novel genes and pseudogenes
journal, December 2003


A lincRNA connected to cell mortality and epigenetically-silenced in most common human cancers
journal, October 2015


Method of Assessing a Propensity of Clinical Outcome for a Female Mammal Suffering from Breast Cancer
patent-application, September 2010


Alternative Export Pathways for Vector Expressed RNA Interference
patent-application, October 2012


Methods for Immortalization of Epithelial Cells
patent-application, May 2017


Polynucleotides Encoding Novel Secreted Proteins
patent-application, April 2002


Direct quantification of gene expression using capillary electrophoresis with laser-induced fluorescence
patent-application, December 2006


Methods for Reducing Protein Levels in a Cell
patent-application, January 2013


Methods for Profiling and Quantitating Cell-free RNA
patent-application, September 2016


Compositions and Methods for Differential Diagnosis of Chronic Lymphocytic Leukemia
patent-application, November 2008